
All things outdoors. Proud dad of boys. Biotech. CEO @Novomebio.
Joined March 2009
- Tweets27
- Following32
- Followers145
- Likes50
Blake Wise retweeted
#News: Excited to share we’ve secured $43.5 million in our Series B financing to advance our ongoing Phase 2a clinical trial in #hyperoxaluria and pipeline of #GEMMs candidates for #IBD. Learn more: novomebio.com #celltherapy #livingmedicines
Today we announced positive results from a Phase 1 clinical trial. This is the first time people have been dosed with a genetically engineered microbe designed to engraft and grow in the human gut. Excited to move on to patients living with enteric hyperoxaluria next!
#News: Excited to share positive Phase 1 results of our orally-administered #GEMM, NOV-001, which produced high levels of engraftment of our engineered strain in the GI tract. Learn more here: https://teapawt.net/t.co/Mm76N88lMP #celltherapy #IBD #livingmedicines
Excited to be partnering with Genentech to advance novel, engineered cell therapies for the gut to treat patients living with IBD!
#News: Exciting day here as we enter a collaboration with @Genentech to leverage our #GEMMs platform to develop targets against inflammatory bowel disease. Learn more here: https://teapawt.net/t.co/0UyMrcoH2m #celltherapy #IBD #livingmedicines
1
Blake Wise retweeted
#News: Excited to share that we’ve appointed Bill McLeod as CFO to broaden our financing experience as we prepare for our next phase of growth. https://teapawt.net/t.co/fYN63I2prB #GEMMs #celltherapy #livingmedicines #CFO
Blake Wise retweeted
Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/
nopatientleftbehind.docsend.…
Blake Wise retweeted
“We believe that our Genetically Engineered Microbial Medicine #celltherapies hold tremendous potential for patients across a wide range of diseases, including #UC and #IBS, in addition to #enterichyperoxaluria,” @blakewise @novomebio #MedTwitter https://teapawt.net/t.co/NLKAGbavPR
Blake Wise retweeted
How a Peninsula biotech hopes to give gut bacteria a boost to boot diseases in first-in-humans clinical trial
#kidneystones
@novomebio bizjournals.com/sanfrancisco… via @SFBusinessTimes
We have initiated our first clinical trial at Novome! This is the first time a human will be dosed with therapeutically engineered bacteria designed to colonize and grow in the gut. I'm excited about the potential to treat patients with enteric hyperoxaluria!
#News: We’ve dosed our first subject in the Phase 1 clinical trial evaluating our once-daily oral #GEMM candidate for the potential treatment of enteric #hyperoxaluria. https://teapawt.net/t.co/477ybKdenT #GEMMs #celltherapy #gutmicrobiome #livingmedicines
1
Blake Wise retweeted
#News: Excited to share we appointed Dr. Lachy McLean as Chief Medical Officer to lead our enteric #hyperoxaluria program into Phase 1/2a proof-of-concept. Learn more here: https://teapawt.net/t.co/1kJCKIqc7T #GEMMs #celltherapy #gutmicrobiome #livingmedicines
Blake Wise retweeted
Excited to share the news that Dave Cook (Forma Therapeutics) and Zach Hornby (Boundless Bio) have joined our Board. Looking forward to their contributions as we expand our GEMMs platform to engineer living medicines for chronic diseases! Learn more here: novomebio.com
Excited to announce @novomebio deal with @CaribouBio that will expand our therapeutic focus and platform capabilities.
We are excited to announce the acquisition of key IP from @CaribouBio, including a license to their CRISPR tools, which will enable new therapeutic opportunities for Novome and accelerate generation of promising therapeutic candidates. Learn more here: globenewswire.com/news-relea…
2
Blake Wise retweeted
We're hiring! Looking for excellent Scientists and Research Associates to join our team, engineering gut bacteria as living medicines for chronic diseases.
Apply @ novomebiotechnologies.applyt…
#hiring #syntheticbiology #synbio #gutbacteria #microbiome #therapeutics
Blake Wise retweeted
Every so often, I re-read Dr. King’s Letter from a Birmingham Jail. While some of the injustices may have changed, his poetic brilliance, moral clarity, and tests of conscience still reverberate today. Take a moment to reflect on his righteous call: theatlantic.com/magazine/arc…
Blake Wise retweeted
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
- by @frankvinluan / insight from CEO @blakewise
xconomy.com/san-francisco/20…
Blake Wise retweeted
With a $35M A round led by @DCVCBio, Novome is enineering microbes to produce a desired biologic after colonizing within the gut. @Novomebio buff.ly/3039rDr
Thrilled to join the talented team at Novome!
Today we’re announcing the close of a $33 million Series A and the appointment of @BlakeWise as CEO. The financing was led by @DCVCBio with participation from @AltaPartners and seed investor @5amVentures. globenewswire.com/news-relea…
Blake Wise retweeted
Critical legislation introduced in @CongressDotGov: Re-Valuing Anti-Microbial Products (REVAMP) Act of 2018 (Shimkus-Cardenas) creates #antibiotic pull incentives that would have a massive impact on companies' ability to address public health crisis https://teapawt.net/t.co/VisLh4Kecg
Blake Wise retweeted
This statement today from FDA Commissioner @SGottliebFDA is the most encouraging sign on a US government pull incentive in many a moon. He calls for paying for rarely-used novel antibiotics more like a software licenses. Worthy topic. fda.gov/NewsEvents/Newsroom/…
Blake Wise retweeted
Opinion: Without inventive approaches to funding the development of new antibiotics, we risk living — and dying — in a post-antibiotic era. buff.ly/2qkp2Nw

















